G01N 2333/974
Thrombin
G01N2333/974 (Thrombin) appears on 278 US grants and 175 published applications in this corpus.
Search patents in G01N- Granted patents
- 278
- Published applications
- 175
- Assignees
- 141
- Inventors
- 489
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 3 | 0 |
| 1995 | 7 | 0 |
| 1996 | 14 | 0 |
| 1997 | 24 | 0 |
| 1998 | 34 | 0 |
| 1999 | 13 | 0 |
| 2000 | 11 | 0 |
| 2001 | 13 | 0 |
| 2002 | 6 | 5 |
| 2003 | 6 | 12 |
| 2004 | 6 | 11 |
| 2005 | 2 | 5 |
| 2006 | 4 | 5 |
| 2007 | 3 | 2 |
| 2008 | 3 | 4 |
| 2009 | 0 | 4 |
| 2010 | 2 | 4 |
| 2011 | 3 | 5 |
| 2012 | 3 | 4 |
| 2013 | 5 | 4 |
| 2014 | 3 | 5 |
| 2015 | 6 | 12 |
| 2016 | 5 | 13 |
| 2017 | 2 | 12 |
| 2018 | 7 | 10 |
| 2019 | 7 | 5 |
| 2020 | 7 | 9 |
| 2021 | 4 | 10 |
| 2022 | 8 | 10 |
| 2023 | 4 | 8 |
| 2024 | 4 | 9 |
| 2025 | 4 | 3 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of diagnosing malignant diseases5 May 2026US 12,618,841 B2St Innovative Diagnostics Ltd
- Biological and/or biochemical and/or chemical sensor21 Apr 2026US 12,607,630 B21). Commissariat A L'energie Atomique Et Aux Energies Alternatives
- Apparatus and method to determine stroke subtype21 Apr 2026US 12,607,641 B2Haemonetics Corporation
- Methods and kits for identifying thrombus origin and optimizing post-ischemic event treatment13 Jan 2026US 12,522,855 B2Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Formation of array of membranes and apparatus therefor4 Nov 2025US 12,458,945 B2Oxford Nanopore Technologies PLC
- Methods and devices for detection of coagulation impairment3 Sep 2026US 2026/0259231 A1Coagulo Medical Technologies, Inc.
- Compositions and methods for logic-gated profiling of biologic activity30 Apr 2026US 2026/0117277 A1Georgia Tech Research Corporation
- Formation of Array of Membranes and Apparatus Therefor12 Mar 2026US 2026/0070034 A1Oxford Nanopore Technologies PLC
- Method for excluding factor xia inhibitors in patient samples5 Mar 2026US 2026/0063650 A1Siemens Healthcare Diagnostics Products GmbH
- Combinatorial high-throughput screening of complex polymeric enzyme immobilization supports19 Jun 2025US 2025/0198980 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups478US 6,121,027 ASurModics, Inc. · 2000
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997